Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
carbapenem |
| gptkbp:approvedBy |
gptkb:FDA
1985 |
| gptkbp:ATCCode |
gptkb:J01DH51
|
| gptkbp:brand |
gptkb:Primaxin
Tienam |
| gptkbp:CASNumber |
74431-23-5
|
| gptkbp:chemicalClass |
gptkb:antibiotic
|
| gptkbp:combines |
gptkb:cilastatin
|
| gptkbp:contraindication |
hypersensitivity to beta-lactams
|
| gptkbp:discoveredBy |
gptkb:Merck_&_Co.
|
| gptkbp:eliminationHalfLife |
1 hour
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C12H17N3O4S
|
| https://www.w3.org/2000/01/rdf-schema#label |
Imipenem
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits cell wall synthesis
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
104838
DB01598 |
| gptkbp:resistantTo |
carbapenemase production
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
nausea
vomiting seizures |
| gptkbp:spectrumOfActivity |
broad-spectrum
|
| gptkbp:target |
penicillin-binding proteins
|
| gptkbp:UNII |
8G6885IS5X
|
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:J01DH03
|
| gptkbp:bfsLayer |
6
|